Marius Hoeper, MD, offers expert perspectives on the recently FDA-approved sotatercept, focusing on its mechanism of action, potential cost implications, and potential advantages and disadvantages it ...

Referral to a PH expert centre, including for right heart catheterisation, confirms the diagnosis. Supportive measures include diuretic therapy for symptoms of right heart failure and fluid retention, ...

Future Cardiol. 2013;9(3):335-349. The pivotal trial that established sildenafil as a treatment for WHO Group 1 PH was the SUPER trial. [102] SUPER enrolled WHO functional class II and III PAH ...

A new study has found that asporin, a protein encoded by the ASPN gene, plays a protective role in pulmonary arterial hypertension (PAH). A new study from researchers with UCLA Health and ...

Pulmonary hypertension remains one of the most challenging and underdiagnosed conditions in respiratory medicine. However, with a well-structured approach and dedicated efforts, significant ...

A recent publication in the International Journal of Cardiology, Pulmonary artery denervation in pulmonary hypertension: A comprehensive meta-analysis, has shed light on the potential of pulmonary ...

In treatment-naïve patients with PAH, initial monotherapy improves exercise capacity, hemodynamics, and outcomes when compared with those noted among untreated patients. In patients who are newly ...

Some illnesses are difficult to recognize and can take months to diagnose. That's the case with pulmonary hypertension. Left untreated, the disease is life-threatening. Fifteen years ago, there were ...

Q: I am an 85-year-old woman, and I’ve been incredibly healthy all my life, until a couple of years ago. Recently, my complaints of breathlessness and fatigue took me to a pulmonologist, who diagnosed ...